Literature DB >> 6224864

Perforated and gangrenous appendicitis: an analysis of antibiotic failures.

P N Heseltine, A E Yellin, M D Appleman, M A Gill, F C Chenella, J W Kern, T V Berne.   

Abstract

The relationships between resistant pathogens, serum levels of gentamicin, and the outcomes of gangrenous or perforated appendicitis were analyzed in 147 patients. Failure to cure the infection occurred significantly more frequently among patients treated with cefoperazone or cefamandole than among those treated with clindamycin and gentamicin in combination. The failures were associated with recovery of resistant Bacteroides fragilis from intraoperative cultures. Pseudomonas species were also associated with failures, their in vitro susceptibility not correlating with clinical cure. Patients with gentamicin peak serum levels of less than 6 micrograms/ml in the first three days were not more likely to be associated with failure than were patients with higher levels. These clinical observations indicate that antibiotic therapy of intra-abdominal sepsis should include antibiotics with in vitro activity against B fragilis and that precise adjustments of gentamicin levels may not improve outcome. In addition, Pseudomonas species may play a significant role in some of these infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224864     DOI: 10.1093/infdis/148.2.322

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

Review 1.  New developments and concepts in antimicrobial therapy for intra-abdominal infections.

Authors:  Z Younes; D A Johnson
Journal:  Curr Gastroenterol Rep       Date:  2000-08

2.  Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.

Authors:  J S Solomkin; E P Dellinger; N V Christou; R W Busuttil
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

3.  National hospital survey of anaerobic culture and susceptibility testing methods: results and recommendations for improvement.

Authors:  E J Goldstein; D M Citron; R J Goldman
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

4.  Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.

Authors:  M E Falagas; L Barefoot; J Griffith; R Ruthazar; D R Snydman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

5.  Surgically treated gangrenous or perforated appendicitis. A comparison of aztreonam and clindamycin versus gentamicin and clindamycin.

Authors:  T V Berne; A E Yellin; M D Appleman; M A Gill; F C Chenella; P N Heseltine
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

Review 6.  Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection.

Authors:  J L Ho; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 7.  Piperacillin/tazobactam in the treatment of polymicrobial infections.

Authors:  S L Gorbach
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

Review 8.  Cephalosporins in surgery. Prophylaxis and therapy.

Authors:  D W McEniry; S L Gorbach
Journal:  Drugs       Date:  1987       Impact factor: 9.546

9.  Effect of peritoneal fluid pH on outcome of aminoglycoside treatment of intraabdominal infections.

Authors:  H P Simmen; H Battaglia; T Kossmann; J Blaser
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

Review 10.  The cephalosporin antibiotics in pediatric therapy.

Authors:  H F Eichenwald; H J Schmitt
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.